Redmile Group’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$120M	Sell	7,732,808 -361,100	-4%	-$5.99M	7.94%	5
2025 Q4	$154M	Buy	8,093,908 +4,415,514	+120%	+$63.4M	11.31%	3
2025 Q3	$34M	Sell	3,678,394 -54,494	-1%	-$566K	3.31%	10
2025 Q2	$42.5M	Sell	3,732,888 -319,039	-8%	-$3.45M	4.53%	7
2025 Q1	$48.1M	Sell	4,051,927 -140,700	-3%	-$2.35M	4.55%	5
2024 Q4	$79M	Sell	4,192,627 -88,354	-2%	-$2.03M	5.51%	3
2024 Q3	$96.2M	Sell	4,280,981 -142,635	-3%	-$3.23M	5.67%	2
2024 Q2	$92.3M	Sell	4,423,616 -59,400	-1%	-$925K	5.58%	3
2024 Q1	$65.9M	Buy	4,483,016 +1,226,497	+38%	+$13.2M	2.42%	12
2023 Q4	$33.6M	Buy	3,256,519 +407,692	+14%	+$2.79M	1.2%	25
2023 Q3	$22.4M	Sell	2,848,827 -8,482	-0.3%	-$77.4K	1.07%	30
2023 Q2	$28.5M	Buy	2,857,309 +107,925	+4%	+$1.1M	1.1%	28
2023 Q1	$24.4M	Sell	2,749,384 -251,400	-8%	-$2.62M	1.06%	38
2022 Q4	$32.9M	Sell	3,000,784 -5,900	-0.2%	-$71.2K	1.35%	24
2022 Q3	$39.2M	Hold	3,006,684	–	–	1.52%	21
2022 Q2	$38.1M	Sell	3,006,684 -12,100	-0.4%	-$137K	1.45%	23
2022 Q1	$42.3M	Buy	3,018,784 +60,500	+2%	+$1.07M	1.32%	21
2021 Q4	$85.6M	Sell	2,958,284 -134,793	-4%	-$4.09M	1.95%	14
2021 Q3	$92.7M	Sell	3,093,077 -97,000	-3%	-$2.99M	1.62%	22
2021 Q2	$84.6M	Sell	3,190,077 -124,040	-4%	-$3.64M	1.25%	26
2021 Q1	$103M	Buy	3,314,117 +467,992	+16%	+$17.7M	1.45%	20
2020 Q4	$93.6M	Buy	2,846,125 +252,555	+10%	+$8.37M	1.13%	27
2020 Q3	$90.5M	Buy	+2,593,570	New	+$65.4M	1.66%	15